Conduct Phase III CT: CDSCO Panel Tells Zydus Healthcare on Glycopyrrolatem plus Indacaterol metered dose inhalation Dr. Divya Colin24 Nov 2024 5:30 PM ISTNew Delhi: Considering the bioequivalence study report presented by Zydus Healthcare, the Subject Expert Committee (SEC) functional under the Central...
Eli Lilly Collaborates with Laekna to Develop Obesity Drug Targeting Muscle Preservation and Weight Loss Farhat Nasim24 Nov 2024 11:00 AM ISTBengaluru: Eli Lilly and Hong Kong-listed Laekna will collaborate to develop an experimental obesity drug that aims to help patients lose weight while...
Despite Pluvicto, MorphoSys Setbacks, Novartis Raises 2028 Sales Growth Outlook to 6% Farhat Nasim24 Nov 2024 10:30 AM ISTFrankfrut: Novartis raised its medium-term sales guidance on Thursday to 6 percent annual growth through 2028, driven by momentum of launched...
Like USFDA, we need Bharat Food and Drug Administration for global benchmarks, says FM Sitharaman Farhat Nasim24 Nov 2024 9:30 AM ISTBengaluru: India is setting standards in pharmaceuticals and like the US Food and Drug Administration (FDA), we should also aim to create Bharat Food...
MSN Laboratories Gets CDSCO Panel nod to Manufacture, Market Tolvaptan Tablets 7.5 mg Dr. Divya Colin23 Nov 2024 5:45 PM ISTNew Delhi: Considering the published data on efficacy studies of Tolvaptan Tablets 7.5 mg, the Subject Expert Committee (SEC) functional under the...
Revise protocol for Denosumab 60 mg prefilled syringe solution for injection: CDSCO Panel tells Lupin Susmita Roy23 Nov 2024 5:30 PM ISTNew Delhi: In line with the proposal presented by Lupin for conducting phase I study of Denosumab 60 mg prefilled syringe solution for injection (60...
Dr Reddy's, Aurobindo Pharma, 4 Others Ink MoUs for Rs 5,260 Crore Pharma City Investment Farhat Nasim23 Nov 2024 1:45 PM ISTThe companies have committed to invest over Rs 5,260 crore, which is expected to create 12,490 job opportunities in the pharma sector
Punjab: Tribunal Slaps Rs 5 Crore Interim Fine on Pharma Unit for Violations Farhat Nasim23 Nov 2024 1:27 PM ISTThe NGT bench also directed the PSPCB to initiate criminal proceedings against the pharma unit for past violations
Torrent Pharma Receives USFDA Clearance for Pithampur Facility with VAI Classification Farhat Nasim23 Nov 2024 12:49 PM ISTMumbai: Torrent Pharmaceuticals Limited has announced that the company received an Establishment Inspection Report (EIR) from the United States...
Marksans Pharma Secures USFDA Nod for Generic Version of Clartin Tablet Farhat Nasim22 Nov 2024 3:03 PM ISTMarksans' product, Loratadine Tablets USP 10 mg are indicated for the treatment of allergic rhinitis.
Pfizer Names Chris Boshoff as New Chief Scientific Officer, R&D Chief Farhat Nasim22 Nov 2024 2:41 PM ISTChris Boshoff will take on the role of chief scientific officer starting Jan 1 & oversee all functions of research & development across all...
Unexo Lifesciences Faces USFDA Heat Over Serious CGMP Violations Farhat Nasim22 Nov 2024 2:13 PM ISTIn response to the issues, the USFDA recommended a voluntary recall of all drug products manufactured at Unexo's facility for the U.S. market.
